Postoperative Radiotherapy for Patients With Completely Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma. Radiol Oncol 2021, 55 (1), 66-76.